Lingbing Li

机构：Chinese PLA General Hospital, Shandong Provincial Hospital, Shandong First Medical University · ORCID：0000-0002-8808-4389

发表论文 47 篇 · 总被引 1040 次 · h-index 19

代表论文

• pH-sensitive polymeric micelles formed by doxorubicin conjugated prodrugs for co-delivery of doxorubicin and paclitaxel (2015 · Carbohydrate Polymers · 被引 112)
• Redox- and MMP-2-sensitive drug delivery nanoparticles based on gelatin and albumin for tumor targeted delivery of paclitaxel (2020 · Materials Science and Engineering C · 被引 57)
• The application of prodrug-based nano-drug delivery strategy in cancer combination therapy (2016 · Colloids and Surfaces B Biointerfaces · 被引 54)
• Linear–dendritic block copolymer for drug and gene delivery (2016 · Materials Science and Engineering C · 被引 52)
• Redox-responsive nanoparticles based on Chondroitin Sulfate and Docetaxel prodrug for tumor targeted delivery of Docetaxel (2020 · Carbohydrate Polymers · 被引 49)
• Advancement of multifunctional hybrid nanogel systems: Construction and application in drug co-delivery and imaging technique (2016 · Materials Science and Engineering C · 被引 47)